AU2012216547B2 - Compositions and methods of treating high temperature subterranean formations - Google Patents

Abstract

COMPOSITIONS AND METHODS OF TREATING HIGH TEMPERATURE SUBTERRANEAN FORMATIONS Compositions and methods of treating high temperature subterranean formations of up to about 500 *F (260 'C) are provided. The compositions and methods utilize a high molecular weight synthetic copolymer and a pH buffer than maintains a pH in a range of about 4.5 to about 5.25 for the compositions. The high molecular weight synthetic copolymer is derived from acrylamide, acrylamidomethylpropanesulfonic acid, and vinyl phosphonate. A high temperature well treatment fluid comprising an electron donating compound comprising phenothiazine as thermal decomposition reduction additives for gels used in well treatment fluids is provided. The electron donating compound comprising phenothiazine performs as a stabilizer in well treatment fluids at temperatures of up to about 500 'F (260 'C).

Description

AUSTRALIA PATENTS ACT 1990 COMPLETE SPECIFICATION FOR A STANDARD PATENT ORIGINAL Name of Applicant: Baker Hughes Incorporated Actual Inventors: Paul S. Carman and Jeffrey C. Dawson Address for Service is: SHELSTON IP 60 Margaret Street Telephone No: (02) 9777 1111 SYDNEY NSW 2000 Facsimile No. (02) 9241 4666 CCN: 3710000352 Attorney Code: SW Invention Title: Compositions and methods of treating high temperature subterranean formations Details of Original Application No. 2009209303 dated 27 Jan 2009 The following statement is a full description of this invention, including the best method of performing it known to me/us: File: 67006AUP01 -2 COMPOSITIONS AND METHODS OF TREATING HIGH TEMPERATURE SUBTERRANEAN FORMATIONS BACKGROUND OF THE INVENTION Field of the Invention 100011 The invention relates to methods and compositions for treating high temperature subterranean formations. More particularly, it relates to methods and compositions for treating a subterranean formation penetrated by a wellbore into which a high temperature well treatment fluid is injected at temperatures of up to about 500 *F (260 *C). The present invention also relates to the use of polymeric compounds as thermal decomposition prevention additives for well treatment fluids. Description of the Related Art 100021 The continued exploration for hydrocarbon-containing subterranean formations is frequently requiring operators to drill significantly deeper than prior drilling operations. Besides drilling deeper, operators are always trying to enhance hydrocarbon production. One way of enhancing hydrocarbon production from many formations is by hydraulic fracturing. In the hydraulic fracturing process, a viscous fracturing fluid is injected into the wellbore at such a rate and pressure so that a crack or fracture is opened into the surrounding formation. Typically, hydraulic fracturing fluids contain guar gum or guar gum derivatives or viscoelastic surfactants as thickeners to assist in proppant transport, friction reduction, fluid loss control, and controlling fracture geometry. The hydraulic fracturing fluids generally transport proppant into the fracture to prevent the fracture from fully closing. Besides being able to place the proppant in the fracture, the fluid must be able to degrade by lowering its viscosity so that a low viscosity fluid results that can be easily cleaned out of the fracture just prior to hydrocarbon production. As the drilling depths continue to increase, the formation temperatures also increase. Unfortunately, as temperatures exceed 325 'F (162.8 *C), many guar-based fracturing fluids are ineffective because they lose their viscosity in part or in whole and therefore become less effective or completely ineffective. Many guar-based fracturing fluids degrade at rates preventing optimum proppant placement, fluid loss control, or fracture geometry. [00031 At high temperatures, guar-based polymers readily undergo auto-degradation by a number of methods, usually within periods of time shorter than what is necessary to complete the -3 fracturing treatment. The degradation generally gets worse as the temperatures continue to increase. Increasing temperatures exasperates this behavior. Most degradation results in the cleavage of the polymer chains, which simultaneously reduces the fluid's viscosity. This can be due to oxidation from residual amounts of air entrained in the fluid, thermal induced cleavage of the acetal linkage along the polymer backbone, hydrolysis of the polymer, or a combination thereof. 100041 Besides use as fracturing fluids, well treatment fluids are useful in hydrocarbon completion operations in various functions, such as being proppant carriers in fracturing processes or as being fluid loss control agents in well completion and workover operations. Well treatment fluids often contain gels that are formed from polymers mixed with water. [00051 As operators continue to drill significantly deeper to access hydrocarbon bearing formations, the conditions in which well treatment fluids must operate often exceeds the maximum operational limits of conventional well treatment fluids. For example, as the drilling depths continue to increase, so do the formation temperatures in which well treatment fluids must operate. Polymeric gels, particularly guar-based polymeric gels, readily undergo auto-degradation by a number of methods at high temperatures, usually within periods of time that are shorter than necessary to complete many well treatment processes. The degradation generally gets worse as the temperatures continue to increase. Most degradation results in the cleavage of the polymer chains, which simultaneously reduces the fluid's viscosity. This can be due to oxidation from residual amounts of air entrained in the fluid, thermal induced cleavage of the acetal linkage along the polymer backbone, or both. 100061 Well treatment fluids use both high pH (alkaline) and low pH (acidic) conditions to crosslink and maintain viscosity. However at elevated temperatures of greater than 300 'F (148.9 *C), acidic or basic hydrolysis can occur which can degrade the viscosity of the well treatment fluid and of the well treatment fluid itself Others have attempted to reduce thermal degradation of polymeric gels by adding a gel stabilizer to the polymeric gel. For example, a stabilizer containing oxime has been used in systems having temperatures as high as 302 *F (150 *C). Unfortunately, many subterranean formations have temperatures well above this level. 100071 A need exists for well treatment fluids containing polymeric gels that are capable of being stabilized at temperatures as high as 500 *F (260 *C) as deeper wells are explored. A need also exists for fracturing fluids that can be used in the deeper and hotter formations that are in -4 operation while simultaneously being able to degrade in a controlled manner when the fracturing process is complete. It is desirable for such fracturing fluids to be stable to enable the fracturing fluids to travel further distances within the fractures. 10007a] Any discussion of the prior art throughout the specification should in no way be considered as an admission that such prior art is widely known or forms part of common general knowledge in the field. 10007b] It is an object of the present invention to overcome or ameliorate at least one of the disadvantages of the prior art, or to provide a useful alternative. SUMMARY OF THE INVENTION 100081 According to a first aspect the invention provides a method of fracturing a subterranean formation comprising: (a) introducing into the subterranean formation at a pressure sufficient to create fractures a high temperature well treatment fluid comprising a polymeric gel and an electron donating compound comprising phenothiazine or a phenothiazine derivative; (b) preventing hydrolysis of the polymeric gel by protecting the site of degradation of the polymeric gel with the electron donating compound; and (c) preventing thermal degradation of the polymeric gel until a temperature of up to about 500 *F (260 *C). [00091 According to a second aspect the invention provides a method of fracturing a subterranean formation comprising the steps of: a) introducing into the formation at a pressure sufficient to create fractures an aqueous high temperature well treatment fluid comprising a polymeric gel and an electron donating compound comprising phenothiazine or a phenothiazine derivative; b) protecting the site of degradation of the polymeric gel with the electron donating compound; and c) preventing thermal degradation of the polymeric gel -5 wherein the phenothiazine or phenothiazine derivative is present in the high temperature well treatment fluid in an amount effective to prevent thermal degradation of the polymeric gel until a temperature of up to about 500 *F (260 *C). 100101 According to a third aspect the invention provides a method of treating a well comprising the steps of: a) pumping into the well an aqueous high temperature well treatment fluid prepared by mixing a polymeric gel and an electron donating compound comprising phenothiazine or phenothiazine derivative; b) protecting the site of degradation of the polymeric gel with the electron donating compound; and c) preventing thermal degradation of the polymeric gel until a temperature of up to about 500 *F (260 C). 100111 Unless the context clearly requires otherwise, throughout the description and the claims, the words "comprise", "comprising", and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense; that is to say, in the sense of "including, but not limited to". [00121 In view of the foregoing, a high temperature well treatment fluid that is capable of fracturing a subterranean formation in temperatures of up to about 500 *F (260 'C) is provided as an embodiment of the present invention. The high temperature well treatment fluid includes water, a high molecular weight synthetic copolymer, a crosslinking agent, and a pH buffer. In an aspect, the high molecular weight synthetic copolymer is derived from acrylamide, acrylamidomethylpropanesulfonic acid, and vinyl phosphonate. In an aspect, the copolymer comprises about 30 - about 80 wt. % acrylamide, about 20 - about 50 wt. % acrylamidomethylpropanesulfonic acid, and about I - about 5 wt. % vinyl phosphonate. The pH buffer enables the high temperature well treatment fluid to maintain a pH in a range of about 4.5 to about 5.25. [0013] Besides high temperature well treatment fluid compositions, methods of fracturing subterranean formations are also provided as embodiments of the present invention. In an embodiment, a method of fracturing a subterranean formation having a temperature of up to about 500 *F (260 *C) is provided. In this embodiment, a high temperature well treatment fluid -6 comprising water; a high molecular weight copolymer derived from acrylamide, acrylamidomethylpropanesulfonic acid, and vinyl phosphonate; a crosslinking agent; and a pH buffer is contacted with at least a portion of the subterranean formation at pressures sufficient to fracture the subterranean formation. The pH buffer maintains a pH of the high temperature well treatment fluid in a range of about 4.5 to about 5.25. [00141 Another method of fracturing a subterranean formation is provided as another embodiment of the present invention. In this embodiment, water is contacted with a high molecular weight copolymer derived from acrylamide, acrylamidomethylpropanesulfonic acid, and vinyl phosphonate to form a water-soluble polymer. The water-soluble polymer is then contacted with a crosslinking agent and a pH buffer to produce a gelling fluid. At least a portion of the subterranean formation is contacted with the gelling fluid at pressures sufficient to fracture the formation. As in other embodiments of the present invention, the pH buffer maintains a pH of the gelling fluid in a range of about 4.5 to about of about 5.25. 100151 Other additives that are useful in high temperature well treatment fluids can also be used in embodiments of the present invention. Such additives can include additional monomers that can be copolymerized with the high molecular weight polymers of the high temperature well treatment fluids, stabilizers to help the high temperature well treatment fluids perform for extended periods of time, crosslinking agents to help increase the viscosity of the high temperature well treatment fluids, breakers to help break down the high temperature well treatment fluids, surfactants that help with hydration of the high temperature well treatment fluids, and the like. Other suitable compounds that are useful in high temperature well treatment fluids, such as proppant and other additives, will be apparent to those of skill in the art and are to be considered within the scope of the present invention. 100161 As another embodiment of the present invention, a high temperature well treatment fluid is provided. In this embodiment, the high temperature well treatment fluid includes a polymeric gel and an electron donating compound comprising phenothiazine that prevents thermal degradation of the polymeric gel at temperatures of up to about 500 *F (260 'C). The high temperature well treatment fluid can be used with various types of polymeric gels that can be crosslinked by ions, including crosslinked guar-based gels and crosslinked synthetic polymeric gels. The well treatment fluid can be used in both high pH and low pH systems.

-7 100171 A method for treating a well penetrating a subterranean formation having a temperature of up to about 500 'F (260 *C) is also provided as another embodiment of the present invention. In this embodiment, the method includes contacting at least a portion of the subterranean formation with a high temperature well treatment fluid. In embodiments of the present invention, the high temperature well treatment fluid includes a polymeric gel and an electron donating compound comprising phenothiazine that prevents thermal degradation of the polymeric gel at temperatures of up to about 500 *F (260 *C). In this embodiment, the high temperature well treatment fluid can be a hydraulic fracturing fluid, a drilling mud, a completion fluid, or a workover fluid. 100181 As yet another embodiment of the present invention, a method of fracturing a subterranean formation having a temperature of up to about 500 'F (260 'C) is provided. In this embodiment, the method includes the steps of contacting water with a high temperature well treatment fluid and contacting the water and the high temperature well treatment fluid with at least a portion of the subterranean formation at pressures sufficient to form fractures in the formation. The high temperature well treatment fluid includes a polymeric gel and an electron donating compound comprising phenothiazine. [00191 Additional additives can be added to the high temperature well treatment fluids of the present invention. Such additives can include additional monomers that can be copolymerized with the polymeric gels of the high temperature well treatment fluids, secondary stabilizers to help the high temperature well treatment fluids perform for extended periods of time, crosslinking agents to help increase the viscosity of the high temperature well treatment fluids, breakers to help break down the high temperature well treatment fluids, surfactants that help with hydration of the high temperature well treatment fluids, and the like. Other suitable additives that are useful in high temperature well treatment fluids, such as proppant, will be apparent to those of skill in the art and are to be considered within the scope of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS [00201 FIG. I is a graph of the apparent viscosity of the high temperature well treatment fluid with and without a breaker versus time at various temperatures in accordance with embodiments of the present invention; -8 [00211 FIG. 2 is a graph of the apparent viscosity of the high temperature well treatment fluid with and without a breaker versus time at 350 *F (176.7 C) in accordance with embodiments of the present invention; [00221 FIG. 3 is a graph of the apparent viscosity of the high temperature well treatment fluid with various amounts of copolymer and temperatures in accordance with embodiments of the present invention; 10023] FIG. 4 is a graph of the apparent viscosity of two guar-based well treatment fluids made with and without an electron donating compound comprising phenothiazine versus time in accordance with embodiments of the present invention; [00241 FIG. 5 is a graph of the apparent viscosity of a high molecular weight synthetic polymer based well treatment fluid made with and without an electron donating compound comprising phenothiazine versus time in accordance with embodiments of the present invention; and 100251 FIG. 6 is another graph of the apparent viscosity of a high molecular weight synthetic polymer-based well treatment fluid made with and without an electron donating compound comprising phenothiazine versus time in accordance with embodiments of the present invention. [0026] While the invention is susceptible to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and will be described in detail herein. However, it should be understood that the invention is not intended to be limited to the particular forms disclosed. Rather, the intention is to cover all modifications, equivalents and alternatives falling within the spirit and scope of the invention as defined by the appended claims. DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS 100271 Illustrative embodiments of the invention are described below as they might be employed in the hydrocarbon recovery operation and in the treatment of well bores. In the interest of clarity, not all features of an actual implementation are described in this specification. It will of course be appreciated that in the development of any such actual embodiment, numerous implementation-specific decisions must be made to achieve the developers' specific goals, which will vary from one implementation to another. Moreover, it will be appreciated that such a development effort might be complex and time-consuming, but would nevertheless be a routine undertaking for those of ordinary skill in the art having the benefit of this disclosure. Further -9 aspects and advantages of the various embodiments of the invention will become apparent from consideration of the following description. 100281 A high temperature well treatment fluid that is capable of fracturing a subterranean formation in temperatures of up to about 500 'F (260 *C) is provided as an embodiment of the present invention. In this embodiment, the high temperature well treatment fluid comprises water, a high molecular weight synthetic copolymer, a crosslinking agent, and a pH buffer. The high molecular weight synthetic copolymer is derived from acrylamide, acrylamidomethylpropanesulfonic acid, and vinyl phosphonate. In an aspect, the acrylamide can be derived from at least one amide of an ethylenically unsaturated carboxylic acid. In an aspect, the high molecular weight synthetic copolymer has a K-value of greater than about 375. In an aspect, the K-value ranges between about 50 to about 750; or alternatively, between about 150 to about 350. The K-value (i.e. Fikentscher's K-value) is a measure of a polymer's average molecular weight. The test method generally used by those skilled in the art to calculate the K value is determined by ISO 1628-2 (DIN 53726). In embodiments of the present invention, the high temperature well treatment fluid comprises about 25 wt. % of the high molecular weight copolymer in an emulsion. The high molecular weight copolymer in emulsion can be present in a range of about 10 gallons per 1,000 gallons high temperature well treatment fluid at temperatures of less than 350 *F (176.7 'C) to about 25 gallons per 1,000 gallons high temperature well treatment fluid at 500 'F (2600 C). The concentration of the high molecular weight synthetic copolymer depends upon the temperature of the subterranean formation and the duration in which the high molecular weight synthetic copolymer will be exposed to the elevated temperatures. In general, more high molecular weight synthetic copolymer is required at higher temperatures than at the lower temperatures. 100291 In an aspect, the copolymer is derived from about 20 - about 90 wt. % acrylamide, about 9 - about 80 wt. % acrylamidomethylpropanesulfonic acid, and about 0.1 - about 20 wt. % vinyl phosphonate; alternatively, about 30 - about 80 wt. % acrylamide, about 25 - about 60 wt. % acrylamidomethylpropanesulfonic acid, and about 0.2 - about 10 wt. % vinyl phosphonate; alternatively, about 40 - about 70 wt. % acrylamide, about 30 - about 40 wt. % acrylamidomethylpropanesulfonic acid, and about 1 - about 3 wt. % vinyl phosphonate; or alternatively, about 50 wt. % acrylamide, about 30 wt. % acrylamidomethylpropanesulfonic acid, about 2 wt. % vinyl phosphonate, and a remainder of copolymers of acrylamide and acrylamidomethylpropanesulfonic acid.

-10 100301 The pH buffer of the present invention helps maintain a low pH of the high temperature well treatment fluid in a range of about 4.5 to about 5.25. In an aspect, the pH buffer comprises acetic acid and sodium acetate. In another aspect, the pH buffer comprises acetic acid, sodium acetate, formic acid, or combinations thereof. The amount of pH buffer that is needed is the amount that will effectively maintain a pH of the high temperature well treatment fluid in a range of about 4.5 to about 5.25; or alternatively, in a range of about 4.75 to about 5; or alternatively, about 5. In an aspect, the pH buffer is a true pH buffer, as opposed to a pH adjuster, as will be understood by those of skill in the art. The low pH of the systems and methods described herein aid in clean up of the fluid after well treatment processes. [00311 At temperatures above 400 'F (204.4 C), a pH buffer comprising acetic acid and sodium acetate having a pH of about 5 at 25% can be used. At temperatures below 400 *F (204.4 *C), other pH buffers can be used, such as acetic acid and formic acid buffers. Generally, any pH buffer capable of maintaining a pH of the high temperature well treatment fluid within in a range of about 4.5 to about 5.25 and without interfering with the remaining components of the high temperature well treatment fluids can be used. Other suitable pH buffers will be apparent to those of skill in the art and are to be considered within the scope of the present invention. 100321 The pH buffer comprising acetic acid and sodium acetate having a pH of about 5 can be used in a concentration ranging from about 1 gallon per 1,000 gallons high temperature well treatment fluid to about 3 gallons per 1,000 gallons high temperature well treatment fluid, depending upon the temperature of the subterranean formation. [00331 The high molecular weight synthetic copolymer can be further copolymerized with other monomers to provide various advantages related to the stability of the high temperature well treatment fluid. Similar to guar-based high temperature well treatment fluids, the viscosity of the high temperature well treatment fluid of the present invention can be significantly enhanced when first copolymerized with small amounts of monomers and crosslinked, at the wellsite, with transition metals, such as iron, titanium, zirconium, chromium, hafnium, aluminum, and combinations thereof Suitable monomers that can be copolymerized with the high molecular weight synthetic polymer include monomers selected from the group consisting of an alkali metal of acrylamidomethylpropanesulfonic acid, an ammonium salt of acrylamidomethylpropanesulfonic acid, styrene sulfonate, vinyl sulfonate, N-vinylpyrolidone, N-vinylformamide, N-vinylacetamide, N,N-diallylacetamide, methacrylamide, acrylamide, N,N-dimethylacrylamide, methacrylamide, a divalent cation from calcium salt, a divalent cation from magnesium salt, and combinations -l1 thereof For example, alkali metal or ammonium salts of acrylamidomethylpropanesulfonic acid (AMPS), styrene sulfonate or vinyl sulfonate can be copolymerized to add salt tolerance to the high molecular weight synthetic polymer. Divalent cations from calcium salt and magnesium salt are also useful for adding salt tolerance to the high molecular weight synthetic polymer. As another example, monomers such as N-vinylamides, N-vinylpyrolidone, N-vinylformamide, N vinylacetamide, and N-diallylacetamide can also be copolymerized with the high molecular weight synthetic polymer to assist in proppant transport by adsorbing onto the proppant surface. The copolymers of the high molecular weight synthetic copolymer can be made by any polymerization method necessary to produce high molecular weight copolymers. A particularly effective method of producing the copolymers is by invert polymer emulsion because it can be easily metered into a flowing stream of water during fracturing processes and it can be made to rapidly hydrate, which may reduce the amount of equipment needed at the wellsite. 100341 The high temperature well treatment fluid of the present invention can also include a stabilizer to help the high temperature well treatment fluids perform for extended periods of time. One manner in which stabilizers assist in extending run times of high temperature well treatment fluids is by maintaining the viscosity of the high temperature well treatment fluid for longer periods of time than the high temperature well treatment fluid would be capable of doing without the stabilizer. In an aspect, the stabilizer is sodium thiosulfate, phenothiazine, or combinations thereof The use of phenothiazine as a stabilizer is described herein. Another suitable stabilizer is a gel stabilizer that is commercially available as GS- IL that contains sodium thiosulfate from BJ Services Company. [00351 In general, any stabilizer compound capable of maintaining viscosity of the high temperature well treatment fluid long enough to perform the fracturing process can be used. The amount of stabilizer that can be used includes an effective amount that is capable of maintaining viscosity, i.e. preventing thermal degradation, of the high temperature well treatment fluid long enough to perform the fracturing process. 100361 In an aspect, the high temperature well treatment fluid of the present invention can also include a crosslinking agent. A suitable crosslinking agent can be any compound that increases the viscosity of the high temperature well treatment fluid by chemical crosslinking, physical crosslinking, or any other mechanisms. For example, the gellation of the high molecular weight synthetic copolymer can be achieved by crosslinking the high molecular weight synthetic copolymer with metal ions including boron, zirconium, and titanium containing compounds, or -12 mixtures thereof One class of suitable crosslinking agents is zirconium-based crosslinking agents. Suitable crosslinking agents can include zirconium oxychloride, zirconium acetate, zirconium lactate, zirconium malate, zirconium glycolate, zirconium lactate triethanolamine, zirconium citrate, titanium lactate, titanium malate, titanium citrate, titanium, aluminum, iron, antimony, a zirconate-based compound, zirconium triethanolamine, an organozirconate, or combinations thereof XLW-1 4 is a particularly suitable zirconate-based crosslinking agent that is commercially available from BJ Services Company and described in U.S. Patent No. 4,534,870, which is incorporated by reference in its entirety. 100371 The amount of the crosslinking agent needed in the high temperature well treatment fluid depends upon the well conditions and the type of treatment to be effected, but is generally in the range of from about 10 ppm to about 1000 ppm of metal ion of the crosslinking agent in the high molecular weight synthetic polymer fluid. In an aspect, the amount of crosslinking agent that can be used includes an effective amount that is capable of increasing the viscosity of the high temperature well treatment fluid to enable it to perform adequately in fracturing processes. In some applications, the aqueous polymer solution is crosslinked immediately upon addition of the crosslinking agent to form a highly viscous gel. In other applications, the reaction of the crosslinking agent can be retarded so that viscous gel formation does not occur until the desired time. 100381 When zirconium is used as a crosslinking agent, zirconium has a built-in delay and is used from 1 gallon per 1,000 gallons to 2 gallons per 1,000 gallons depending on the temperature and high molecular weight synthetic polymer concentration in the high temperature well treatment fluid. If extra stability time is required, an additional stabilizer, such as sodium thiosulfate (e.g., GS-IL from BJ Services), can be used in a range of about 1 gallon per 1,000 gallons high temperature well treatment fluid to about 3 gallons per 1,000 gallons high temperature well treatment fluid. 100391 The high temperature well treatment fluid of the present invention can also include a surfactant to aid in well treatment processes. Surfactants typically aid in the hydration of the high molecular weight synthetic polymer. Without the surfactant, the high temperature well treatment fluids of the present invention can take up to about 20 to 30 minutes to adequately hydrate. With the addition of the surfactant, the hydration time is substantially reduced. With the surfactant, the hydration can take less than 5 minutes. 90 - 95 % of the high temperature well treatment fluid of the present invention can be hydrated in about 1 to 2 minutes with a suitable surfactant. The type -13 and concentration of the surfactant can control the hydration time of the high temperature well treatment fluid. Any suitable surfactant can be used, as will be apparent to those of skill in the art. In an aspect, a nonionic surfactant such as an ethoxylated alcohol can be used. A suitable surfactant that can be used in the present invention is a proprietary blend of two different surfactants commercially available from Rhodia. The Rhodia blend contains 50 wt. % Rhodasurf BC 720, which is an alkoxypoly(ethyleneoxy)ethanol surfactant, and an ethoxylated long chain alcohol having between 10 and 18 carbon molecules. In an aspect, the surfactant comprises alkoxypoly(ethyleneoxy)ethanol, an ethoxylated alcohol having from 10 to 18 carbon molecules, and combinations thereof Effective types and amounts of suitable surfactants will be apparent to those of skill in the art and are to be considered within the scope of the present invention. 100401 In an aspect of the present invention, the high temperature well treatment fluid also includes a breaker that is capable of degrading the high temperature well treatment fluid in a controlled manner to assist operators in clean up and removal of the high temperature well treatment fluid when the well treatment process is complete. For example, the breakers can assist in clean-up efforts after fracturing treatments. Viscometer tests have shown that most breakers that contain oxidizing agents are useful in the degradation of the fluid. Suitable oxidizing agents can include sodium bromate, ammonium persulfate, sodium persulfate, sodium perborate, sodium percarbonate, calcium peroxide, magnesium peroxide and sodium periodate. Controlled degradation can be recognized because it results in a simultaneous and controlled reduction in fluid viscosity. Testing suggests that the stability of the high temperature well treatment fluid of the present invention, even with the intentional addition of the breakers that contain oxidizing agents, greatly exceeds that obtained by guar-based well treatment fluids, allowing optimized treatments to be employed at well temperatures ranging from 250 OF (121.1 0 C) to 500 *F (260 *C). [00411 In an aspect, the breaker comprises sodium bromate, either as is or encapsulated. Sodium bromate has been shown to easily degrade the high temperature well treatment fluid in a controlled manner. In an aspect, the breaker comprises sodium bromate, ammonium persulate, sodium persulfate, sodium perborate, sodium percarbonate, calcium peroxide, magnesium peroxide, sodium periodate, an alkaline earth metal percarbonate, an alkaline earth metal perborate, an alkaline earth metal peroxide, an alkaline earth metal perphosphate, a zinc peroxide, a zinc perphosphate, a zinc perborate, a zinc percarbonate, a boron compound, a perborate, a peroxide, a perphosphate, or combinations thereof In an aspect, the breaker comprising sodium -14 bromate, ammonium persulate, sodium persulfate, sodium perborate, sodium percarbonate, calcium peroxide, magnesium peroxide, sodium periodate, or combinations thereof Other types and amounts of suitable breakers that can be used in the present invention will be apparent to those of skill in the art are to be considered within the scope of the present invention. 100421 When sodium bromate is used to break the high temperature well treatment fluid of the present invention, the concentration of the sodium bromate can be from about 0.5 ppt high temperature well treatment fluid to 20 ppt high temperature well treatment fluid. The concentration will depend on if the sodium bromate is run as a solid, a solution, or encapsulated, such as High Perm BRTM Gel Breaker from BJ Services Company. [00431 The pH buffers, stabilizers, crosslinking agents, breakers, monomers, and other additives described herein can be used in the method embodiments as well as the compositional embodiments of the present invention. Other suitable compounds for high temperature well treatment fluids, such as proppant and other additives, will be apparent to those of skill in the art and are to be considered within the scope of the present invention. [0044] Besides the compositions of the high temperature well treatment fluid, methods of fracturing a subterranean formation having a temperature of up to about 500 *F (260 *C) are provided as embodiments of the present invention. In one embodiment, a high temperature well treatment fluid is contacted with at least a portion of the subterranean formation at pressures sufficient to fracture the subterranean formation. In an aspect, the high temperature well treatment fluid includes water; a high molecular weight polymer comprising acrylamide, acrylamidomethylpropanesulfonic acid, and vinyl phosphonate; a crosslinking agent; and a pH buffer that maintains a pH of the high temperature well treatment fluid in a range of about 4.5 to about 5.25. [00451 Another method of fracturing a subterranean formation is provided as another embodiment of the present invention. In this embodiment, water is contacted with a high molecular weight copolymer derived from acrylamide, acrylamidomethylpropanesulfonic acid, and vinyl phosphonate to form a water-soluble polymer that is then contacted with a crosslinking agent and a pH buffer to produce a gelling fluid. The gelling fluid is then contacted with at least a portion of the subterranean formation at pressures sufficient to fracture the formation. As with other embodiments of the present invention, the pH buffer maintains a pH of the gelling fluid in a range of about 4.5 to about of about 5.25.

-15 [00461 The compositions and methods described herein perform well when compared with traditional guar-based well treatment fluids. Well treatment fluids require sufficient viscosity that lasts long enough for the well treatment fluid to complete the well treatment process, such as fracturing. The compositions and methods describe herein are stabilized for much longer than most prior art well treatment fluids at elevated temperatures. For example, the high temperature well treatment fluid of the present invention can be pumped at a temperature of up to about 500 'F (260 'C) for a period of up to about 2 hours. The high temperature well treatment fluid can be pumped at a temperature of up to about 425 "F (218.3 *C) for a period of up to about 4 hours. The high temperature well treatment fluid can be pumped at a temperature of up to about 400 'F (204.4 *C) for a period of up to about 6 hours. 100471 As an embodiment of the present invention, a high temperature well treatment fluid is provided. In this embodiment, the high temperature well treatment fluid includes a polymeric gel and an electron donating compound comprising phenothiazine. The electron donating compound comprising phenothiazine is present in the high temperature well treatment fluid in an effective gel stabilizing amount that prevents thermal degradation of the polymeric gel at temperatures of up to about 500 *F (260 *C). Phenothiazine has a molecular structure as follows: H 100481 As discussed herein, hydrolysis can occur when traditional polymeric gels are exposed to elevated temperatures of greater than about 300 'F (148.9 'C). The hydrolysis process can be slowed down by protecting the site of the degradation with the electron donating compound. The electron donating compound of the present invention comprises phenothiazine, which is a very good antioxidant and free radical scavenger. Phenothiazine can donate electrons to satisfy charge of surrounding molecules. The electron donating compound functions as a high temperature stabilizer for the high temperature well treatment fluid. Phenothiazine is also an effective chain terminator because it has a sufficiently high molecular weight to terminate further reactions. 100491 Phenothiazine is commonly used an intermediate chemical for various psychotropic drugs, as well as an insecticide. Phenothiazine, which is also called dibenzothiazine or thiodiphenylamine, can be prepared by fusing diphenylamine with sulfur. Other suitable methods of preparing phenothiazine will be apparent to those of skill in the art and are to be considered within the scope of the present invention.

-16 100501 In an aspect, phenothiazine can include various phenothiazine derivatives. The phenothiazine can include unsubstituted phenothiazine, unsubstituted phenothiazine 5-oxide derivative, unsubstituted phenothiazine hydrohalogenide derivative, alkyl-substituted phenothiazine, aryl-substituted phenothiazine, aroyl-substituted phenothiazine, carboxyl substituted phenothiazine, halogen-substituted phenothiazine, N-(dialkylaminoalkyl)-substituted phenothiazine, phenothiazine-5 -oxide, alkyl-substituted phenothiazine-5 -oxide, aryl-substituted phenothiazine-5-oxide, aroyl-substituted phenothiazine-5 -oxide, carboxyl-substituted phenothiazine-5-oxide, halogen-substituted phenothiazine-5-oxide, N-(dialkylaminoalkyl) substituted phenothiazine-5-oxide, the hydrochlorides of these compounds, or combinations thereof. In another aspect, phenothiazine can include phenothiazine, 3-phenylphenothiazine, N phenylphenothiazine, phenothiazine-5-oxide, 10,1 0'-diphenylphenothiazine, n benzoylphenothiazine, 7-benzoylphenothiazine, 3,7-difluorophenothiazine, N-ethylphenothiazine, 2-acetylphenothiazine, 3,7-dioctylphenothiazine, N-methylphenothiazine-5 -oxide, N acetylphenothiazine, N-(2-diethylaminoethyl)-phenothiazine, N-(2-dimethylaminopropyl) phenothiazine, N-(2-dimethylaminopropylphenothiazine)-hydrochloride,

N

octadecylphenothiazine, N-propylphenothiazine, or combinations thereof. Any of the phenothiazine compounds described herein can be used as phenothiazine in embodiments of the present invention. 100511 In an embodiment, the electron donating compound comprising phenothiazine can be present in a range of about 100 ppm to about 250 ppm of the high temperature well treatment fluid; alternatively, in a range of about 110 ppm to about 200 ppm; alternatively, in a range of about 120 ppm to about 150 ppm; or alternatively, in a range of about 120 ppm to about 140 ppm. 100521 The electron donating compound comprising phenothiazine of the present invention can be used with various types of polymeric gels that are polymers crosslinked by ions. For example, the polymeric gel can be derived from a crosslinked polymer selected from the group consisting of galactomannan gums and their derivatives, glucomannan gums and their derivatives, guar gum, locust bean gum, cara gum, carboxymethyl guar, hydroxyethyl guar, hydroxypropyl guar carboxymethyihydroxyethyl guar, carboxymethylhydroxypropyl guar cellulose, cellulose derivatives, hydroxypropyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, carboxymethyl cellulose, acrylamide, polyvinyl alcohol, a copolymer of acrylamide, and combinations thereof. In an aspect, the polymeric gel includes a high molecular weight copolymer -17 derived from acrylamide. Use of a high molecular weight copolymer derived from acrylamide is described herein. The polymeric gels can also be used in the method embodiments of the present invention described herein. Other suitable polymers can be used in the present invention, as will be understood by those of skill in the art, and are to be considered within the scope of the present invention. [0053] The phenothiazine can be supplied at a concentration of about 40 pounds per 1,000 gallons well treatment fluid to sufficiently stabilize the well treatment fluid at 400 *F (204.4 *C). Because of the shorter pumping times that are required at temperatures of less than 350 *F (176.7 *C), less phenothiazine can be used. For example, about 30 pounds per 1,000 gallons well treatment fluid is sufficient to stabilize the well treatment fluid at temperatures of less than about 350 *F (176.7 -C). In another aspect, the phenothiazine can be present in an amount effective to provide a gelled composite throughout the use of the high temperature well treatment fluid in oilfield hydraulic fracturing, drilling, completion, or workover operations. 100541 Because phenothiazine is not soluble in water, a solution is necessary to deliver the chemical to well treatment fluids. Several solvents, including glycol ethers and esters, can be used to dissolve the phenothiazine. It was calculated that to effectively stabilize a fluid system a concentration of about 120 ppm phenothiazine in high temperature well treatment fluid was needed based upon stability data of the high temperature well treatment fluid. A suitable concentration of the electron donating compound comprising phenothiazine can be present in a range of about 100 ppm to about 250 ppm of the high temperature well treatment fluid; alternatively, in a range of about 110 ppm to about 200 ppm; alternatively, in a range of about 120 ppm to about 150 ppm; or alternatively, in a range of about 120 ppm to about 140 ppm. It is believed that solutions around 9 wt. % to 10 wt. % of phenothiazine in solution provided the best concentration for additive loadings and pour point. Toluene can also be used as a solvent to dissolve the phenothiazine. A suitable solvent is commercially available as Arcosolve@ DPM, which contains dipropylene glycol methyl ether. In an aspect, the solvent is toluene, a glycol ether, a glycol ester, or combinations thereof Other suitable solvents and effective amounts of such solvents will be apparent to those of skill in the art and are to be considered within the scope of the present invention. [00551 The high temperature well treatment fluid can include various additives along with the polymeric gel and electron donating compound comprising phenothiazine. In an aspect, the high temperature well treatment fluid further includes a crosslinking agent in an amount sufficient to -18 crosslink the polymeric gel. A suitable crosslinking agent can be any compound that increases the viscosity of the high temperature well treatment fluid by chemical crosslinking, physical crosslinking, or any other mechanisms. For example, the gellation of the polymer can be achieved by crosslinking the high molecular weight synthetic polymer with metal ions including boron, zirconium, and titanium containing compounds, or mixtures thereof One class of suitable crosslinking agents is zirconium-based crosslinking agents. In another aspect, the crosslinking agent includes zirconium oxychloride, zirconium acetate, zirconium lactate, zirconium malate, zirconium glycolate, zirconium lactate triethanolamine, zirconium citrate, titanium lactate, titanium malate, titanium citrate, titanium, aluminum, iron, antimony, a zirconate-based compound, zirconium triethanolamine, an organozirconate, or combinations thereof Other suitable crosslinking agents will be apparent to those of skill in the art and are to be considered within the scope of the present invention. 100561 The amount of the crosslinking agent needed in the high temperature well treatment fluid depends upon the well conditions and the type of treatment to be effected, but is generally in the range of from about 10 ppm to about 1000 ppm of metal ion of the crosslinking agent in the high molecular weight synthetic polymer fluid. In some applications, the aqueous polymer solution is crosslinked immediately upon addition of the crosslinking agent to form a highly viscous gel. In other applications, the reaction of the crosslinking agent can be retarded so that viscous gel formation does not occur until the desired time. 100571 When zirconium is used as a crosslinking agent, zirconium has a built-in delay and is used from 1 gallon per 1,000 gallons to 2 gallons per 1,000 gallons depending on the temperature and high molecular weight synthetic polymer concentration in the high temperature well treatment fluid. If extra stability time is required, an additional secondary stabilizer, such as sodium thiosulfate (e.g., GS- IL from BJ Services), can be used in a range of about 1 gallon per 1,000 gallons high temperature well treatment fluid to about 3 gallons per 1,000 gallons high temperature well treatment fluid. [0058] In an aspect of the present invention, the high temperature well treatment fluid can also include a breaker that is capable of degrading the high temperature well treatment fluid in a controlled manner to assist operators in clean up and removal of the high temperature well treatment fluid when the well treatment process is complete. For example, the breakers can assist in clean-up efforts after fracturing treatments.

-19 100591 Suitable breakers that can be used in the present invention will be apparent to those of skill in the art. In an aspect, the breaker comprises sodium bromate, either as is or encapsulated. In an aspect, the breaker comprises sodium bromate, ammonium persulfate, sodium persulfate, sodium perborate, sodium percarbonate, calcium peroxide, magnesium peroxide, sodium periodate, an alkaline earth metal percarbonate, an alkaline earth metal perborate, an alkaline earth metal peroxide, an alkaline earth metal perphosphate, a zinc peroxide, a zinc perphosphate, a zinc perborate, a zinc percarbonate, a boron compound, a perborate, a peroxide, a perphosphate, or combinations thereof. In an embodiment, the breaker comprises sodium bromate, ammonium persulfate, sodium persulfate, sodium perborate, sodium percarbonate, calcium peroxide, magnesium peroxide, sodium periodate, or combinations thereof 100601 The present invention can work in both high pH and low pH systems. As can be seen in the examples, the high temperature well treatment fluid can be used in systems having high pH values that range from about 9 to about 11. As can also be seen in the examples, the low temperature well treatment fluid can be used in systems having low pH values that range from about 4.5 to about 5.25. 100611 In an aspect, the high temperature well treatment fluid can include a pH buffer. The pH buffer of the present invention helps maintain a low pH of the high temperature well treatment fluid in a range of about 4.5 to about 5.25. In another aspect, the pH buffer comprises acetic acid and sodium acetate. In another aspect, the pH buffer comprises acetic acid, sodium acetate, formic acid, or combinations thereof The amount of pH buffer that is needed is the amount that will effectively maintain a pH of the high temperature well treatment fluid in a range of about 4.5 to about 5.25; or alternatively, in a range of about 4.75 to about 5; or alternatively, about 5. In an aspect, the pH buffer is a true pH buffer, as opposed to a pH adjuster, as will be understood by those of skill in the art. 100621 At temperatures above 400 *F (204.4 C), a pH buffer comprising acetic acid and sodium acetate having a pH of 5 at 25% can be used. At temperatures below 400 *F (204.4 *C), other pH buffers can be used, such as acetic acid and formic acid buffers. Generally, any pH buffer capable of maintaining a pH of the high temperature well treatment fluid within in a range of about 4.5 to about 5.25 can be used and without interfering with the remaining components of the high temperature well treatment fluids. Other suitable pH buffers will be apparent to those of skill in the art and are to be considered within the scope of the present invention.

-20 100631 The pH buffer comprising acetic acid and sodium acetate having a pH of 5 can be used in a concentration ranging from about 1 gallon per 1,000 gallons high temperature well treatment fluid to about 3 gallons per 1,000 gallons high temperature well treatment fluid, depending upon the temperature of the subterranean formation. 100641 Besides phenothiazine, the electron donating compound of the present invention can also include other compounds that are suitable for use as a secondary stabilizer. The electron donating compound functions as a stabilizer that is capable of stabilizing well treatment fluids at temperatures above what conventional stabilizers are capable of doing. Secondary stabilizers (i.e., conventional stabilizers) can be used to help the high temperature well treatment fluids perform for extended periods of time by acting as an oxygen scavenger. Secondary stabilizers can also help reduce hydrolysis, which can be a problem at temperatures greater than about 400 *F (204.4 *C). [00651 One manner in which the electron donating compounds assist in extending run times of high temperature well treatment fluids is by maintaining the viscosity of the high temperature well treatment fluid for longer periods of time than the high temperature well treatment fluid would be capable of doing without the electron donating compound stabilizer. The secondary stabilizers can be used to help boost the stabilizing ability of the electron donating compound comprising phenothiazine, particularly at temperatures greater than about 400 *F (204.4 *C). 100661 In an aspect, the electron donating compound can include a secondary stabilizer comprising sodium thiosulfate. A suitable secondary stabilizer that contains sodium thiosulfate is commercially available as GS-I L from BJ Services Company. Other suitable secondary stabilizers and effective amounts of such secondary stabilizers will be apparent to those of skill in the art and are to be considered within the scope of the present invention. In general, any secondary stabilizer compound capable of reducing or scavenging oxygen in the high temperature well treatment fluid long enough to perform the well treatment process (e.g., fracturing process) can be used. The amount of secondary stabilizer that can be used includes an effective amount that is capable of reducing or scavenging oxygen of the high temperature well treatment fluid long enough to perform the well treatment process (e.g., fracturing process). 100671 Additional additives can be added to the high temperature well treatment fluid, as needed and as will be apparent to those of skill in the art. For example, proppant can be included within the high temperature well treatment fluid in embodiments of the present invention.

-21 100681 As another embodiment of the present invention, a method for treating a well penetrating a subterranean formation having a temperature of up to about 500 *F (260 *C) is provided. In this embodiment, a high temperature well treatment fluid is contacted with at least a portion of the subterranean formation. The high temperature well treatment fluid comprises a polymeric gel and an electron donating compound comprising phenothiazine. The electron donating compound comprising phenothiazine prevents thermal degradation of the polymeric gel at temperatures of up to about 500 *F (260 C). In an aspect, the electron donating compound comprising phenothiazine can be present in a range of about 100 ppm to about 250 ppm of the high temperature well treatment fluid; alternatively, in a range of about 110 ppm to about 200 ppm; alternatively, in a range of about 120 ppm to about 150 ppm; or alternatively, in a range of about 120 ppm to about 140 ppm. 100691 The method embodiments of the present invention can be used on various types of high temperature well treatment fluids. For example, in an aspect, the high temperature well treatment fluid can be a hydraulic fracturing fluid. In another aspect, the high temperature well treatment fluid can be a completion fluid. In another aspect, the high temperature well treatment fluid can be a workover fluid. It is believed that embodiments of the present invention will perform adequately in drilling, completion operations, and workover operations that typically use a comparable composition that is used in fracturing operations. For example, multi-viscous fluids are sometimes used for both completion operations and fracturing operations. It is believed that the electron donating compound comprising phenothiazine would be suitable in such applications. 100701 As indicated previously, the polymeric gels, pH buffers, breakers, secondary stabilizers, and other additives can be used in the method embodiments described herein. Other suitable additives for high temperature well treatment fluids, such as a proppant, will be apparent to those of skill in the art and are to be considered within the scope of the present invention. 100711 A method of fracturing a subterranean formation having a temperature of up to about 500 *F (260 0 C) is provided as another embodiment of the present invention. In this embodiment, water is contacted with a high temperature well treatment fluid comprising a polymeric gel and an electron donating compound comprising phenothiazine. At least a portion of the subterranean formation is contacted with the water and the high temperature well treatment fluid at pressures sufficient to form fractures in the formation. In this embodiment, the electron donating compound is present in an effective polymeric gel stabilizing amount that prevents thermal degradation of the polymeric gel at temperatures of up to about 500 OF (260 *C). In an aspect, the electron donating -22 compound is present in a range of about 100 ppm to about 250 ppm of the high temperature well treatment fluid; alternatively, in a range of about 110 ppm to about 200 ppm; alternatively, in a range of about 120 ppm to about 150 ppm; or alternatively, in a range of about 120 ppm to about 140 ppm. [00721 Care should be taken in using the compositions and methods described herein to not over stabilize the well treatment fluid because it must be broken down to remove the well treatment fluid from the wellsite at the end of the well treatment process. Typically, operators try to stabilize the well treatments for as long as possible. The high temperature electron donating compound stabilizers of the present invention perform so well at stabilizing well treatment fluids, a balance is needed to ensure that the stabilizer comprising phenothiazine adequately stabilizes the well treatment fluid, while ensuring that the operator will be able to remove the well treatment fluid easily at the end of the treatment. 100731 The methods and compositions of the present invention do not require any new or additional equipment. Traditional well treatment fluid equipment can be used without any modification. The methods and compositions of the present invention can be used in subterranean formations having higher temperatures than many prior art well treatment fluids are capable of functioning properly.

-23 EXAMPLES Example 1 100741 Samples of the high temperature well treatment fluid of the present invention were prepared by mixing 40 pounds of copolymer derived from acrylamide and acrylamidomethylpropanesulfonic acid in one thousand gallons (ppt) tap water and allowed to hydrate for 30 minutes. A suitable copolymer that was used in this example is commercially available as Allessan@ AG 5028P from Allessa Chemie. The order of addition of the additives is as it appears in FIG. 1. As shown in FIG. 1, the apparent viscosity in centipoises (cP) was measured and plotted for the high temperature well treatment fluid at temperatures ranging from 300 *F (148.9 *C) to 500 *F (260 'C) using a R 1

B

5 bob and cup combination against time in minutes. FIG. I shows stability of the high temperature well treatment fluid of the present invention without the use of breakers. The pH was controlled using two different pH buffers. As indicated in FIG. 1, some of the samples were added as a dry powder to the fracturing fluid, while others were prepared in an emulsion. A pH of 4.5 with acetic acid (BF-10L by BJ Services Company) was used in the samples up to 400 *F (204.4 C). A pH of 4.76 with a true buffer of pH 4.5 (BF-1 8L by BJ Services Company) was used in the samples that were greater than 400 *F (204.4 'C). 2.5 to 3.0 gpt of a zirconate-based crosslinking agent (XLW-14 by BJ Services Company) was used in the samples. Two samples were made and measured at 400 OF (204.4 C), one of the samples was prepared with 0.06 wt. % sodium thiosulfate gel stabilizer and the other sample was prepared without the stabilizer. As can be seen in FIG. 1, the sample at 400 OF (204.4 'C) with the stabilizer performed much better than the sample without the stabilizer, i.e., it maintained its viscosity for a longer period of time than the sample without the stabilizer. Example 2 100751 Three samples of the high temperature well treatment fluid of the present invention were prepared by mixing 40 pounds of copolymer derived from acrylamide, acrylamidomethylpropanesulfonic acid, and vinyl phosphonate in one thousand gallons tap water (Allessan® AG 5028P from Allessa Chemie) and allowed to hydrate for 30 minutes. The order of addition of the additives is as it appears in FIG. 2. As shown in FIG. 2, the apparent viscosity was measured and plotted for the high temperature well treatment fluid at 350 *F (176.7 'C) using a

R

1

B

5 bob and cup combination against time in minutes. The pH was controlled using I gpt of acetic acid to pH 4.5 (e.g., BF-OL by BJ Services Company). 2.5 gallons per 1,000 gallons high -24 temperature well treatment fluid (gpt) of a zirconate-based crosslinking agent (e.g., XLW-14 by BJ Services Company) was used in the samples. The first sample was made without the use of a breaker. The second and third samples were prepared with one and three ppt respectively of an encapsulated sodium bromate labeled as High Perm Br in FIG. 2 (High Perm BR T M Gel Breaker from BJ Services Company). As can be seen in FIG. 2, the viscosity tapers off at a consistent rate with each of the samples that contain the sodium bromate breaker, which indicates that the high temperature well treatment fluid can be degraded in a controlled manner. The viscosity of the second sample with I ppt breaker decreased slower than the viscosity of the third sample having 3 ppt breaker. Example 3 100761 Three samples of the high temperature well treatment fluid of the present invention were prepared by mixing varying amounts of copolymer derived from acrylamide, acrylamidomethylpropanesulfonic acid, and vinyl phosphonate with tap water (Allessan@ AG 5028P with a built in stabilizer from Allessa Chemie) and allowed to hydrate for 30 minutes. The components, order of addition, and conditions in this example are as follows: Component/Condition Sample 1 Sample 2 Sample 3 Copolymer (AG 5028P), ppt 25 40 50 Gel stabilizer (GS- 1 L), gpt 1 2 2 Buffer (BF-65L), gpt 1 1.5 2 Crosslinking agent (XLW-65), gpt 1.5 1.5 2 Temperature, 'F ('C) 350 (176.7) 400 (204.4) 450 (232.2) The gel stabilizer GS-1L, buffer BF-65L, and crosslinking agent XLW-65 are all commercially available from BJ Services Company. As shown in FIG. 3, the apparent viscosity was measured and plotted for the high temperature well treatment fluid at temperatures ranging from 350 *F (176.7 *C) to 450 *F (232.2 'C) using a RIB 5 bob and cup combination against time in minutes. The pH was controlled using a true 5.0 pH buffer (e.g., BF-65L by BJ Services Company). As can be seen in FIG. 3, the viscosity tapers off at a consistent rate with each of the samples, which -25 indicates that the high temperature well treatment fluid can be stable for an extended period of time and still be degraded in a controlled manner. Example 4 100771 The electron donating compound comprising phenothiazine was mixed at 360 'F (182.2 'C) with two guar-based fracturing fluids that are commercially available under the commercial names Medallion Frac HT@ and Vistar@ from BJ Services Company. In addition order, tap water, 10 wt. % methanol, 12.5 gpt of the (slurried polymer XLFC-3 or VSP-l by BJ Services Company respectively for Medallion Frac HT@ and Vistar@) I gpt Claytreat-3C clay stabilizer (CT-3C) by BJ Services Company, 3 gpt stabilizer (GS-IL) by BJ Services Company, 0.2 gpt crosslink delay agent (XLD-1) by BJ Services Company, and 1.4 gpt zirconate-based crosslinker (XLW-14) by BJ Services Company were mixed with 50 ppt of the fracturing fluid to produce the samples. The pH of the Medallion Frac HT@ system was about 10 and the pH of the Vistar@ system was about 10.25. The concentration of the electron donating compound comprising phenothiazine was 120 ppm in the fracturing fluid, i.e., 3 gpt 9.7 wt. % in dipropylene glycol methyl ether (ARCOSOLVETM DPM) by Lyondell Chemical. As can be seen in FIG. 4, Medallion Frac HT® fluid and Vistar@ fluid performed better with the stabilizing electron donating compound comprising phenothiazine added to them than without it at 360 'F (182.2 'C). The viscosity of the fracturing fluids was maintained without substantial degradation for at least 25 minutes longer than without the electron donating compound comprising phenothiazine added to it.

-26 Example 5 [00781 Three samples were prepared in this example. The first sample was the control sample. In the second and third samples, the electron donating compound stabilizer comprising phenothiazine was mixed at varying amounts at 400 *F (204.4 *C) with 40 ppt high molecular weight polymer based fracturing fluid comprising a copolymer derived from acrylamide. A suitable copolymer that was used in this example is commercially available as Allessan@ AG 5028P from Allessa Chemie. The pH of the samples prepared in this example was about 5. In addition order, tap water, 10 wt. % methanol, 19.1 gpt of the polymer emulsion, 1 gpt Claytreat-3C clay stabilizer (CT-3C) by BJ Services Company, 3 gpt stabilizer (GS- IL) by BJ Services Company, 2.0 gpt zirconate-based crosslinker (XLW-65) by BJ Services Company and 2 gpt low pH buffer (BF 65L) by BJ Services Company were mixed to produce the samples. The high molecular weight polymer-based fracturing fluid was made in accordance with methods described herein. Along with the polymer, a secondary stabilizer that is commercially available as GS-1 L from BJ Services Company, an acetic acid sodium acetate buffer that maintains a pH of about 5, and a crosslinking agent commercially available as XLW-65 from BJ Services Company were used to create the fracturing fluid. 100791 The first sample contained 3 gpt GS-1 L stabilizer, 2 gpt acetic acid sodium acetate buffer, and 2 gpt XLW-65 from BJ Services Company crosslinking agent, with no electron donating compound stabilizer comprising phenothiazine. The electron donating compound stabilizer comprising phenothiazine was added to the second and third samples of the polymer-based fracturing fluid at a concentration of 2 gallons per 1,000 gallons fracturing fluid and 4 gallons per 1,000 gallons fracturing fluid respectively. The phenothiazine was saturated in a toluene solvent (in 3 - 4 wt. % solution) to aid in delivering the phenothiazine to the fracturing fluid. Besides the 2 gpt phenothiazine, the second sample contained 3 gpt GS-1 L stabilizer, 2 gpt acetic acid sodium acetate-pH buffer, and 2 gpt XLW-65crosslinking agent. The third sample contained 2 gpt GS 1 L stabilizer, 3 gpt acetic acid sodium acetate-pH buffer, and 2 gpt XLW-65 crosslinking agent, in addition to the 4 gpt phenothiazine. 100801 As can be seen in FIG. 5, the polymer-based fracturing fluid performed much better with the electron donating compound stabilizer comprising phenothiazine added to it than without it. The viscosity of the fracturing fluids was maintained at higher values than without the electron donating compound stabilizer comprising phenothiazine added to it. The third sample maintained -27 its viscosity the longest out of the three samples. The more phenothiazine-containing electron donating compound stabilizer that was in the sample, the more stable the fracturing fluid in this example. Example 6 100811 Five samples were prepared in this example. The first top sample was the control sample at 400 'F (204 *C). In the remaining samples, the electron donating compound stabilizer comprising phenothiazine was mixed at varying amounts at 400 'F (204.4 *C) with 40 ppt or 50 ppt high molecular weight polymer-based fracturing fluid comprising a copolymer derived from acrylamide, as indicated in Table 1. A suitable copolymer that was used in this example is commercially available as Allessan@ AG 5028P from Allessa Chemie. The components, addition order, and conditions in this example are as follows: Table I Component/Condition Sample 1 Sample 2 Sample 3 Sample 4 Sample 5 Copolymer (AG 5028P), 40 40 40 40 50 ppt Gel stabilizer (GS-I L), 3 3 2 2 1.5 gpt Buffer, gpt 2 2 3 3 2 Crosslinking agent 2 2 2 2 2 (XLW-65), gpt Stabilizer, gpt - 2 4 4 4 Temperature, 'F (*C) 400 400 400 425 450 100821 The samples were allowed to hydrate for 30 minutes. The pH of the samples prepared in this example was about 5. The high molecular weight polymer-based fracturing fluid was made in accordance with methods described herein. As shown in Table 1, along with the polymer, a secondary stabilizer that is commercially available as GS- 1 L from BJ Services Company, an acetic acid pH buffer that maintains a pH of 5, and a crosslinking agent commercially available as XLW 65 from BJ Services Company were used to create the fracturing fluid. 100831 As can be seen in FIG. 6, the polymer-based fracturing fluid performed much better with the electron donating compound stabilizer comprising phenothiazine added to it than without it. The viscosity of the fracturing fluids was maintained at higher values than without the electron donating compound stabilizer comprising phenothiazine added to it. The third sample maintained -28 its viscosity the longest out of the three samples at 400'F (204.4 'C). The more phenothiazine containing electron donating compound stabilizer that was in the sample, the more stable the fracturing fluid in this example. 100841 While the invention has been shown or described in only some of its forms, it should be apparent to those skilled in the art that it is not so limited, but is susceptible to various changes without departing from the scope of the invention. For example, various types of additives can be used in the high temperature well treatment fluid of the present invention. As another example, various types of equipment can be used for the well treatment processes described herein.

Claims (21)

1. 2. The method of claim 1, wherein the high temperature well treatment fluid further contains a crosslinking agent.
2. 3. The method of claim 1 or claim 2, wherein the polymeric gel comprises a crosslinked polymer.
3. 4. The method of claim 3, wherein the polymeric gel comprises a crosslinked polymer derived from a polymer selected from the group consisting of galactomannan gums and their derivatives, glucomannan gums and their derivatives, guar gum, locust bean gum, cara gum, carboxymethyl guar, hydroxyethyl guar, hydroxypropyl guar, carboxymethylhydroxyethyl guar, carboxymethylhydroxypropyl guar cellulose, cellulose derivatives, hydroxypropyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, carboxymethyl cellulose, acrylamide, polyvinyl alcohol, a copolymer of acrylamide, and combinations thereof.
4. 5. The method of any one of claims I to 4, wherein the electron donating compound comprising phenothiazine or phenothiazine derivative is present in a range of about 100 ppm to about 250 ppm of the high temperature well treatment fluid.
5. 6. The method of any one of claims 1 to 5, wherein the high temperature well treatment fluid further comprises a pH buffer that maintains a pH of the high temperature well treatment fluid in a range of about 4.5 to about 5.25.
6. 7. The method of claim any one of claims 1 to 6, wherein the phenothiazine or phenothiazine derivative is selected from the group consisting of unsubstituted phenothiazine, unsubstituted phenothiazine 5-oxide derivative, unsubstituted phenothiazine hydrohalogenide derivative, alkyl-substituted phenothiazine, aryl-substituted phenothiazine, aroyl-substituted phenothiazine, carboxyl-substituted phenothiazine, -30 halogen-substituted phenothiazine, N-(dialkylaminoalkyl)-substituted phenothiazine, phenothiazine-5 -oxide, alkyl-substituted phenothiazine-5-oxide, aryl-substituted phenothiazine-5-oxide, aroyl-substituted phenothiazine-5-oxide, carboxyl-substituted phenothiazine-5-oxide, halogen-substituted phenothiazine-5 -oxide, N-(dialkylaminoalkyl) substituted phenothiazine-5-oxide, the hydrochlorides of these compounds, or combinations thereof
7. 8. The method of any one of claims 1 to 7, wherein the electron donating compound further comprises sodium thiosulfate.
8. 9. A method of fracturing a subterranean formation comprising the steps of: a) introducing into the formation at a pressure sufficient to create fractures an aqueous high temperature well treatment fluid comprising a polymeric gel and an electron donating compound comprising phenothiazine or a phenothiazine derivative; b) protecting the site of degradation of the polymeric gel with the electron donating compound; and c) preventing thermal degradation of the polymeric gel wherein the phenothiazine or phenothiazine derivative is present in the high temperature well treatment fluid in an amount effective to prevent thermal degradation of the polymeric gel until a temperature of up to about 500 *F (260 0 C).
9. 10. The method of claim 9, wherein the electron donating compound comprising phenothiazine or phenothiazine derivative is present in a range of about 100 ppm to about 250 ppm of the high temperature well treatment fluid.
10. 11. The method of claim 9 or claim 10, wherein the aqueous high temperature well treatment fluid further comprises a crosslinking agent.
11. 12. The method of any one of claims 9 to 11, wherein the polymeric gel comprises a crosslinked polymer derived from a polymer selected from the group consisting of galactomannan gums and their derivatives, glucomannan gums and their derivatives, guar gum, locust bean gum, cara gum, carboxymethyl guar, hydroxyethyl guar, hydroxypropyl guar, carboxymethylhydroxyethyl guar, carboxymethylhydroxypropyl guar, hydroxypropyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, carboxymethyl cellulose, acrylamide, polyvinyl alcohol, a copolymer of acrylamide, and combinations thereof. -31
12. 13. The method of any one of claims 9 to 12, wherein the electron donating compound further comprises sodium thiosulfate.
13. 14. A method of treating a well comprising the steps of: a) pumping into the well an aqueous high temperature well treatment fluid prepared by mixing a polymeric gel and an electron donating compound comprising phenothiazine or phenothiazine derivative; b) protecting the site of degradation of the polymeric gel with the electron donating compound; and c) preventing thermal degradation of the polymeric gel until a temperature of up to about 500 *F (260 *C).
14. 15. The method of claim 14, wherein the aqueous high temperature well treatment fluid is a drilling mud, a completion fluid or a workover fluid.
15. 16. The method of claim 14 or 15, wherein the electron donating compound further comprises sodium thiosulfate.
16. 17. The method of any one of claims 14 to 16, wherein the phenothiazine or phenothiazine derivative is solubilized in toluene, a glycol ether or a glycol ester.
17. 18. The method of any one of claims 14 to 17, wherein the phenothiazine or phenothiazine derivative is selected from the group consisting of unsubstituted phenothiazine, unsubstituted phenothiazine 5-oxide derivative, unsubstituted phenothiazine hydrohalogenide derivative, alkyl-substituted phenothiazine, aryl-substituted phenothiazine, aroyl-substituted phenothiazine, carboxyl-substituted phenothiazine, halogen-substituted phenothiazine, N-(dialkylaminoalkyl)-substituted phenothiazine, phenothiazine-5-oxide, alkyl-substituted phenothiazine-5 -oxide, aryl-substituted phenothiazine-5-oxide, aroyl-substituted phenothiazine-5 -oxide, carboxyl-substituted phenothiazine-5-oxide, halogen-substituted phenothiazine-5-oxide, N-(dialkylaminoalkyl) substituted phenothiazine-5-oxide, the hydrochlorides of these compounds, or combinations thereof
18. 19. The method of any one of claims 14 to 18, wherein the aqueous high temperature well treatment fluid further comprises a crosslinking agent.
19. 20. The method of any one of claims 14 to 19, wherein the polymeric gel is a crosslinked polymer. -32
20. 21. A method of fracturing a subterranean formation according to claim I or claim 9 and substantially as herein descrined with reference to enay one of the embodiments of the invention illustrated in the accompanying drawings and/or examples.
21. 22. A method of treating a well according to claim 14 and substantially as herein descrined with reference to enay one of the embodiments of the invention illustrated in the accompanying drawings and/or examples.